You are here

  • Home
  • Archive
  • Volume 79, Issue 7
  • Response to: ‘Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al’ by Knitza et al

Article Text

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al’ by Knitza et al
Free
  1. Anna Tjärnlund,
  2. Ingrid E Lundberg
  1. Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
  1. Correspondence to Professor Ingrid E Lundberg, Rheumatology, Stockholm SE-17176, Sweden; ingrid.lundberg{at}ki.se

https://doi.org/10.1136/annrheumdis-2019-215515

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have with great interest read the letter entitled ‘Response to: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al’ by Knitza et al, to be published in the Annals of the Rheumatic Diseases.1

    We appreciate the thoughtful comments made by the authors and agree on the importance of aminoacyl transfer RNA synthetase (ARS) autoantibodies, as well as other autoantibodies for correct classification of the associated diseases. The discussion stems from the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) …

    View Full Text

    Linked Articles